Filter Results
:
(128)
Show Results For
- All HBS Web (128)
- Faculty Publications (9)
Show Results For
- All HBS Web (128)
- Faculty Publications (9)
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby largely...
View Details
Keywords:
Dina Gerdeman
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say there are two big issues with...
View Details
- Web
Biotechnology | Baker Library | Bloomberg Center | Harvard Business School
Library Databases Ask Us Special Collections Fast Answers All Services Hours Plan Your Visit Exhibits Hollis Working Knowledge HBS Home About Academic Programs Alumni Faculty & Research Baker Library Campaign Harvard Business Review...
View Details
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
Edited by Margie Kelley Alumni Books You Got This! A Straightforward, No-Nonsense Playbook for Crushing 130+ Workplace Challenges By Heidi Abelli (MBA 1993) Palmetto Publishing Stepping into the corporate world can feel like navigating a labyrinth, especially when...
View Details
- 21 Oct 2015
- Research & Ideas
How to Predict if a New Business Idea is Any Good
industry like drug development, it’s not like you can just switch from one disease to another disease,” she says. While R&D-intensive ventures can shift the application of their underlying technology, Shu continues, the fact they are...
View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx....
View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of...
View Details
Keywords:
by F. Warren McFarlan & Richard L. Nolan
- Web
Medical Devices | Baker Library | Bloomberg Center | Harvard Business School
Library Databases Ask Us Special Collections Fast Answers All Services Hours Plan Your Visit Exhibits Hollis Working Knowledge HBS Home About Academic Programs Alumni Faculty & Research Baker Library Campaign Harvard Business Review...
View Details
- Web
Industry Information - Alumni
regulatory issues, technology news, and marketing trends. Frost & Sullivan Healthcare Report Provides actionable market, technical, and econometric research. A global team of industry experts continuously monitor the following Healthcare market sectors: pharmaceuticals...
View Details
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
direct special attention to it." Similarly, Daguerre, who invented photography, made his breakthrough when he put an exposed plate into a cabinet in which a thermometer had earlier shattered; mercury vapors from the broken...
View Details
Keywords:
by Sarah Jane Gilbert
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business...
View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more...
View Details
Keywords:
by Sean Silverthorne
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
Where to find biotech and pharmaceuticals R&D spending and product cost data? Bloomberg – use BI function to locate R&D spending data Cortellis - special database on pharmaceuticals industry including R&D...
View Details
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from...
View Details
- Student-Profile
Olivia Zhao
the social sciences were very appealing to me. Also, all the questions I found most interesting were being studied there by economists, so I wanted to learn how to use their methods to make meaning out of data. “As for why I chose to View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
Alumni gathered in New York City in November for a dynamic case discussion — a special benefit for members of the HBS Fund Investors Society. John Quelch, the Charles Edward Wilson Professor of Business Administration at HBS, joined...
View Details
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to...
View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
practices to understand principles,” Porter has said. As part of that effort, and emerging from his trip, Porter and several GHD colleagues have written a case study, “HIV Care in Rwanda,” that was the subject of a special seminar at HBS...
View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every...
View Details
Keywords:
Julia Hanna
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been...
View Details